NASDAQ:AMGN
Amgen Inc.
- Stock
$
industry
Drug Manufacturers / Generalexchange
NASDAQ Global Selectwebsite
www.amgen.comipo date
May 01, 1987full time employees
25,200currency
USD
Amgen is a leader in biotechnology-based human therapeutics, with historical expertise in renal disease and cancer supportive-care products. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory disease...Show More
Earnings
Earnings per Share (Estimate)
Revenue (Estimate)
Revenue Breakdown
Segment | Revenue |
---|---|
Product | 24.30B |
Product And Service | 1.68B |